title: [Aspirin use for the primary prevention of cardiovascular disease and cancer: reflections on the 2016 U.S. Preventive Services Task Force recommendation statement].
authors.affiliation: Cattedra di Cardiologia, Dipartimento di Medicina Clinica e Molecolare, Sapienza Università di Roma, Roma, e IRCCS Neuromed, Pozzilli (IS).
authors.forename: Massimo
authors.initials: M
authors.lastname: Volpe
mesh_terms: D001241:Aspirin / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D009369:Neoplasms / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011322:Primary Prevention / Q000379:methods; D014481:United States
chemical_list: D010975:Platelet Aggregation Inhibitors; D001241:Aspirin